// App-Quantinova.ai

1914 : HBsAg and HBcrAg as predictors of seroconversion in a pan‐genotypic population of hepatitis B e antigen positive patients treated with nucleos(t)ide analogues

Researchers

Presenter

  • Bo Wang

Principal Investigators

  • Matthew Bruce

  • Sarah Montague

  • Geoffrey M. Dusheiko

  • Kosh Agarwal

  • Ivana Carey

Medical Centers

  • Institute of Liver Studies, Kings CollegeHospital NHS Trust, London , United Kingdom

  • UCL Medical School, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Hepatitis B

Biomarkers

  • Hepatitis B surface antigen

  • Hepatitis B e antigen

  • Hepatitis B core-related antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved